Wells Fargo & Company Nevro Corp Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Nevro Corp stock. As of the latest transaction made, Wells Fargo & Company holds 21,595 shares of NVRO stock, worth $123,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,595

Previous 16,624 29.9%

Holding current value

$123,739

Previous $92,000 13.04%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$3.59 - $5.78 $17,845 - $28,732	4,971 Added 29.9%	21,595 $80,000
Q3 2024 Nov 13, 2024	BUY	$4.71 - $10.1 $433 - $929	92 Added 0.56%	16,624 $92,000
Q2 2024 Aug 13, 2024	BUY	$7.96 - $13.59 $30,884 - $52,729	3,880 Added 30.67%	16,532 $139,000
Q1 2024 May 10, 2024	BUY	$13.56 - $20.78 $18,482 - $28,323	1,363 Added 12.07%	12,652 $182,000
Q4 2023 Feb 09, 2024	BUY	$14.18 - $22.31 $29,990 - $47,185	2,115 Added 23.05%	11,289 $242,000
Q3 2023 Nov 13, 2023	SELL	$18.22 - $25.85 $104,017 - $147,577	-5,709 Reduced 38.36%	9,174 $176,000
Q2 2023 Aug 15, 2023	BUY	$22.62 - $39.32 $108,100 - $187,910	4,779 Added 47.3%	14,883 $378,000
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $261,815 - $356,752	8,678 Added 608.56%	10,104 $365,000
Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $118,943 - $161,291	-3,265 Reduced 69.6%	1,426 $56,000
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $47,328 - $61,726	-1,164 Reduced 19.88%	4,691 $220,000
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $270,549 - $514,408	-6,623 Reduced 53.08%	5,855 $257,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $717,661 - $1.1 Million	-11,971 Reduced 48.96%	12,478 $902,000
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $345,277 - $516,574	-4,259 Reduced 14.84%	24,449 $1.98 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $758,499 - $1.24 Million	-7,437 Reduced 20.58%	28,708 $3.34 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $1.42 Million - $1.8 Million	-10,025 Reduced 21.71%	36,145 $5.99 Million
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $1.63 Million - $2.24 Million	-12,297 Reduced 21.03%	46,170 $6.44 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $1.29 Million - $1.72 Million	9,338 Added 19.01%	58,467 $10.1 Million
Q3 2020 Nov 05, 2020	SELL	$114.09 - $145.51 $2.11 Million - $2.69 Million	-18,486 Reduced 27.34%	49,129 $6.84 Million
Q2 2020 Aug 13, 2020	SELL	$89.45 - $129.85 $1.5 Million - $2.18 Million	-16,787 Reduced 19.89%	67,615 $8.08 Million
Q1 2020 May 14, 2020	BUY	$70.23 - $144.31 $5.93 Million - $12.2 Million	84,402 New	84,402 $8.44 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

37.6M

Call Options Held

622K

Put Options Held

1.39M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $203M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Nevro Corp Transaction History